Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival

Some biomarkers in CRC are useful for stratifying patients more appropriately for adjuvant treatment and could be used to evaluate patients overall outcome, to monitor chances of recurrence after standard treatment. Co-expression of programmed cell death- 1 (PD-1), programmed cell death- ligand 1...

Full description

Bibliographic Details
Main Author: Onwe, Ebenyi Emeka
Format: Thesis
Language:English
Published: 2020
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/90388/1/FPSK%28m%29%202020%2011%20-%20IR.pdf
_version_ 1796982309013946368
author Onwe, Ebenyi Emeka
author_facet Onwe, Ebenyi Emeka
author_sort Onwe, Ebenyi Emeka
collection UPM
description Some biomarkers in CRC are useful for stratifying patients more appropriately for adjuvant treatment and could be used to evaluate patients overall outcome, to monitor chances of recurrence after standard treatment. Co-expression of programmed cell death- 1 (PD-1), programmed cell death- ligand 1 (PD-L1), thymidylate synthase (TYMS), and deleted in colorectal carcinoma (DCC) biomarkers are not widely studied in CRC simultaneously. This study aimed to evaluate PD-1, PD-L1, TYMS, and DCC expression in tissue blocks collected from CRC patients who attend Hospital Serdang, Selangor Malaysia. Ninety one formalin fixed paraffin embedded (FFPE) archival tumour samples from patients who underwent surgical resection, were assessed using mmunohistochemical (IHC) method. There was high expression of DCC detected in 84.6% (77/91) in most cases. TYMS expression at high level was 46.2% (42/91) and low level was 53.8% (49/91) respectively. Majority of cases showed low PD-L1 expression in 93.4% (86/91) and high expression was detected in 6.6% (6/94) of cases. PD-1 expression was low in all cases. There was a significant association between TYMS expression with gender (P < 0.05) with distribution of TYMS expression at high level was 76.2% in male and 23.8% in female. The Kaplan-Meier survival plot showed that overall survival (OS) mean was 94 months and disease free survival (DFS) mean was 110 months. A Log rank test showed there was no statistical significance between PDL1, TYMS and DCC with OS and DSF patients. In conclusion, the results from this study suggest that PD-L1, TYMS and DCC expression could be used as biomarkers to predict treatment outcome in CRC, PD-L1 overexpression predict patients who could benefit from anti-PD-1 and anti-P D-L1 immunotherapy, TYMS low expression predict patients who could benefit from 5-fluorouracil therapy and DCC high expression tumours predicts a better prognosis and overall survival than DCC low expression in advanced CRC.
first_indexed 2024-03-06T10:50:08Z
format Thesis
id upm.eprints-90388
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:50:08Z
publishDate 2020
record_format dspace
spelling upm.eprints-903882021-08-18T02:26:32Z http://psasir.upm.edu.my/id/eprint/90388/ Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival Onwe, Ebenyi Emeka Some biomarkers in CRC are useful for stratifying patients more appropriately for adjuvant treatment and could be used to evaluate patients overall outcome, to monitor chances of recurrence after standard treatment. Co-expression of programmed cell death- 1 (PD-1), programmed cell death- ligand 1 (PD-L1), thymidylate synthase (TYMS), and deleted in colorectal carcinoma (DCC) biomarkers are not widely studied in CRC simultaneously. This study aimed to evaluate PD-1, PD-L1, TYMS, and DCC expression in tissue blocks collected from CRC patients who attend Hospital Serdang, Selangor Malaysia. Ninety one formalin fixed paraffin embedded (FFPE) archival tumour samples from patients who underwent surgical resection, were assessed using mmunohistochemical (IHC) method. There was high expression of DCC detected in 84.6% (77/91) in most cases. TYMS expression at high level was 46.2% (42/91) and low level was 53.8% (49/91) respectively. Majority of cases showed low PD-L1 expression in 93.4% (86/91) and high expression was detected in 6.6% (6/94) of cases. PD-1 expression was low in all cases. There was a significant association between TYMS expression with gender (P < 0.05) with distribution of TYMS expression at high level was 76.2% in male and 23.8% in female. The Kaplan-Meier survival plot showed that overall survival (OS) mean was 94 months and disease free survival (DFS) mean was 110 months. A Log rank test showed there was no statistical significance between PDL1, TYMS and DCC with OS and DSF patients. In conclusion, the results from this study suggest that PD-L1, TYMS and DCC expression could be used as biomarkers to predict treatment outcome in CRC, PD-L1 overexpression predict patients who could benefit from anti-PD-1 and anti-P D-L1 immunotherapy, TYMS low expression predict patients who could benefit from 5-fluorouracil therapy and DCC high expression tumours predicts a better prognosis and overall survival than DCC low expression in advanced CRC. 2020-10 Thesis NonPeerReviewed text en http://psasir.upm.edu.my/id/eprint/90388/1/FPSK%28m%29%202020%2011%20-%20IR.pdf Onwe, Ebenyi Emeka (2020) Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival. Masters thesis, Universiti Putra Malaysia. Disease-Free Survival Colorectal Neoplasms
spellingShingle Disease-Free Survival
Colorectal Neoplasms
Onwe, Ebenyi Emeka
Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival
title Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival
title_full Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival
title_fullStr Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival
title_full_unstemmed Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival
title_short Prognostic value of PD-1, PD-L1, TYMS and DCC in colorectal carcinoma and association with overall and disease-free survival
title_sort prognostic value of pd 1 pd l1 tyms and dcc in colorectal carcinoma and association with overall and disease free survival
topic Disease-Free Survival
Colorectal Neoplasms
url http://psasir.upm.edu.my/id/eprint/90388/1/FPSK%28m%29%202020%2011%20-%20IR.pdf
work_keys_str_mv AT onweebenyiemeka prognosticvalueofpd1pdl1tymsanddccincolorectalcarcinomaandassociationwithoverallanddiseasefreesurvival